Cantor Fitzgerald Starts MyoKardia (MYOK) at Overweight
Cantor Fitzgerald analyst Alethia Young initiates coverage on MyoKardia (NASDAQ: MYOK) with a Overweight rating and a price target of $90.00.
For an analyst ratings summary and ratings history on MyoKardia click here. For more ratings news on MyoKardia click here.
Shares of MyoKardia closed at $65.20 yesterday.